Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Vanessa Perez-Gomez

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Clinical Kidney Journal|February 22, 2020
Aliskiren and the dual complement inhibition conceptMaria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|September 8, 2020
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrologySol Carriazo, Maria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|September 29, 2015
Haemodialysate: long neglected, difficult to optimize, may modify hard outcomesMaria Vanessa Perez-Gomez, Emilio Gonzalez-Parra, Alberto Ortiz
Clinical Kidney Journal|October 30, 2020
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney diseaseRaul Fernandez-Prado, Maria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|June 6, 2022
The mysterious death of the beer drinking champ: potential role for hyperacute water loading and acute hyponatremiaMaria Vanessa Perez-Gomez, Didier Sanchez-Ospina, Alberto Tejedor, et al.
Clinical Kidney Journal|August 11, 2018
Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease developmentMaria Vanessa Perez-Gomez, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez, et al.
Therapeutic Advances in Drug Safety|August 25, 2015
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal functionRaquel Esteras, Maria Vanessa Perez-Gomez, Laura Rodriguez-Osorio, et al.
Clinical Kidney Journal|March 14, 2019
Podocyturia: why it may have added value in rare diseasesMaria Dolores Sanchez-Niño, Maria Vanessa Perez-Gomez, Lara Valiño-Rivas, et al.
Clinical Kidney Journal|November 3, 2022
Gain-of-function <i>TLR7</i> and loss-of-function <i>A20</i> gene variants identify a novel pathway for Mendelian lupus and lupus nephritisPriscila Villalvazo, Sol Carriazo, Jorge Rojas-Rivera, et al.
Clinical Kidney Journal|December 4, 2023
Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKDSol Carriazo, Marta Ribagorda, Aranzazu Pintor-Chocano, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|February 22, 2020
Aliskiren and the dual complement inhibition conceptMaria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|September 8, 2020
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrologySol Carriazo, Maria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|September 29, 2015
Haemodialysate: long neglected, difficult to optimize, may modify hard outcomesMaria Vanessa Perez-Gomez, Emilio Gonzalez-Parra, Alberto Ortiz
Clinical Kidney Journal|October 30, 2020
Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney diseaseRaul Fernandez-Prado, Maria Vanessa Perez-Gomez, Alberto Ortiz
Clinical Kidney Journal|June 6, 2022
The mysterious death of the beer drinking champ: potential role for hyperacute water loading and acute hyponatremiaMaria Vanessa Perez-Gomez, Didier Sanchez-Ospina, Alberto Tejedor, et al.
Clinical Kidney Journal|August 11, 2018
Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease developmentMaria Vanessa Perez-Gomez, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez, et al.
Therapeutic Advances in Drug Safety|August 25, 2015
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal functionRaquel Esteras, Maria Vanessa Perez-Gomez, Laura Rodriguez-Osorio, et al.
Clinical Kidney Journal|March 14, 2019
Podocyturia: why it may have added value in rare diseasesMaria Dolores Sanchez-Niño, Maria Vanessa Perez-Gomez, Lara Valiño-Rivas, et al.
Clinical Kidney Journal|November 3, 2022
Gain-of-function <i>TLR7</i> and loss-of-function <i>A20</i> gene variants identify a novel pathway for Mendelian lupus and lupus nephritisPriscila Villalvazo, Sol Carriazo, Jorge Rojas-Rivera, et al.
Clinical Kidney Journal|December 4, 2023
Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKDSol Carriazo, Marta Ribagorda, Aranzazu Pintor-Chocano, et al.
Pageof 4